| Stock Symbol | 6945.TW |
|---|---|
| Company Status | Public Company |
| Industry | Biotechnology and Medicine |
| Main Business | New Drug Development |
| Date of Registration | May 27th, 2013 |
| Total Paid-in Capital (NT$) | 647,479,100 |
| Name of Representative | Frank Chen |
| Chief Executive Officer | Jeng-Horng Her |
| Location of Company | 11F.-2, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City 115011, Taiwan (R.O.C.) |
| Office | +886-2-2653-2886 |
| service@apbioinc.com | |
| Website | www.apbioinc.com |
| Stock Transfer Agent | MasterLink Securities Co., Ltd. |
| Accounting Firm | PwC Taiwan |
